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Abstract
This study was designed to identify metalloproteinase determinants of macrophage migration and led to the specific
hypothesis that matrix metalloproteinase 10 (MMP10/stromelysin-2) facilitates macrophage migration. We first profiled
expression of all MMPs in LPS-stimulated primary murine bone marrow-derived macrophages and Raw264.7 cells and
found that MMP10 was stimulated early (3 h) and down-regulated later (24 h). Based on this pattern of expression, we
speculated that MMP10 plays a role in macrophage responses, such as migration. Indeed, using time lapse microscopy,
we found that RNAi silencing of MMP10 in primary macrophages resulted in markedly reduced migration, which was
reversed with exogenous active MMP10 protein. Mmp102/2 bone marrow-derived macrophages displayed significantly
reduced migration over a two-dimensional fibronectin matrix. Invasion of primary wild-type macrophages into Matrigel
supplemented with fibronectin was also markedly impaired in Mmp102/2 cells. MMP10 expression in macrophages thus
emerges as an important moderator of cell migration and invasion. These findings support the hypothesis that MMP10
promotes macrophage movement and may have implications in understanding the control of macrophages in several
pathologies, including the abnormal wound healing response associated with pro-inflammatory conditions.
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Introduction
Matrix metalloproteinases (MMPs) are a family of highly
conserved, zinc-dependent endopeptidases with a range of
functions in immunity, tissue repair and other disease processes.
[1,2]. In healthy tissue the activity of MMPs is tightly regulated
with a delicate balance between activation and inhibition, which
is mediated largely by the endogenous tissue inhibitors of
metalloproteinases (TIMPs). Once activated, MMPs act on a
variety of extracellular proteins, including extracellular matrix
(ECM) components and the ectodomains of membrane proteins.
This can have consequences on cell-matrix interactions and
subsequent migration, cytokine signalling, and leukocyte activa-
tion in both normal and pathological processes (reviewed in
[3,4,5]). The broad and varied function of MMPs highlights the
importance of expanding our understanding of these proteinases
in disease pathology, including inflammation and impaired
wound healing.
Macrophages express a number of MMPs and are key players
in several repair processes and pathologies, including the wound
healing process. Human macrophages and their monocytic
precursors can express a range of MMPs [6,7,8] and this
expression profile is modulated during the process of differen-
tiation from precursor monocyte to macrophage, concomitant
with morphological changes, such as cell adhesion and
spreading [9,10]. Induction of macrophage MMP expression
can be driven by pro-inflammatory stimuli, such as TNFa,
gram-negative lipopolysaccharide (LPS), and type II interferons
[7,8,11].
The activation of leukocytes in response to LPS via TLR4/NF-
kB signalling is well-characterised, including an important role in
the transcription of some MMPs. For example, pharmacological
inhibition of NF-kB translocation into the nucleus, in both
primary monocytes and cell lines in vitro, represses the expression
of several MMPs [12,13]. In vivo and ex vivo studies have also
revealed a clear relationship between LPS and MMP expression in
a variety of tissues [14,15].
The migration of macrophages, and indeed other highly motile
cells, is greatly influenced by the composition of the local ECM
[16], affecting both the persistence and directionality of migration
in vivo (reviewed in [17,18]). Advances in our understanding of
proteinase-dependent cell migration/invasion have come from
studies assessing expression and function of MMPs during
migration on or through various matrix components that would
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be present in or around sites of diapedesis [19,20,21,22]. In
macrophages, MMP14 has been localised to the cell’s leading edge
[23] and more recently around podosomes, actin-rich adhesions,
in dendritic cells where it is thought to play a role in cell protrusion
[24].
In vivo evidence supports the idea that certain MMPs may be
involved both positively and negatively in monocyte/macro-
phage migration. Thus Johnson and colleagues [25] have shown
that macrophages are dependent on TIMP2-inhibitable MMP
activity for in vivo colonisation of atherosclerotic plaques (as well
as in vitro migration). Similarly, double Mmp22/2/Mmp92/2
monocytes from knockout mice show reduced infiltration,
suggestive of a reduction in migration, across the parenchymal
basement membrane in an experimental autoimmune enceph-
alomyelitis (EAE) model [26]. Conversely, MMPs can also exert
a negative influence on macrophage migration in vivo. For
example, macrophage recruitment in lungs following Pseudomonas
aeruginosa infection is restrained by MMP28, whilst macrophages
isolated from infected Mmp282/2 mice migrate more rapidly
towards relevant bronchiolar lavage components in vitro [7].
Certain MMPs play key roles in fine-tuning the chemokine and
growth factor response, particularly during the resolution of
wound healing and associated inflammation (reviewed in [27]).
For example, macrophages have been shown to control the
clearance and recruitment of neutrophils in wounds by secreting
MMP12 to cleave and inactivate pro-neutrophil chemokines
CXCL-5 and -8. Over time MMP12 further contributes to the
degradation of pro-monocyte/macrophage chemokines CCL2, 7,
8 and 13, disrupting their own recruitment to bring about the
resolution of inflammation [4].
Given the implication of MMP expression in inflammatory
pathologies we have taken an unbiased approach to determine
murine macrophage expression of all MMPs following LPS
stimulation. These studies reveal differential and time-dependent
modulation of MMP10 expression in response to LPS. Further
experiments revealed a novel role for MMP10 in macrophage
migration and invasion.
Materials and Methods
Materials
Unless otherwise stated all chemical reagents were purchased
from Sigma-Aldrich Corp. (St. Louis, MO, USA), all tissue culture
reagents from Gibco Invitrogen Corp. (Paisley, Scotland, UK) and
all tissue culture plastics from Nunc Thermo Fisher Scientific
(Rochester, NY, USA).
Bone Marrow-derived Macrophages
Bone Marrow-derived Macrophages (BMDM) were isolated
from the femurs and tibias of C57Bl/6 mice (according to
institutional guidelines and UK Home Office requirements)
essentially as previously described [28]. Briefly, bone marrow
was flushed from the bone cavity with a 21 g needle and syringe
(BD, Oxford, UK) containing macrophage medium consisting of
Roswell Park Memorial Institute (RPMI) 1640 liquid medium
containing 100 units/ml penicillin/streptomycin antibiotic, 5 mM
L-glutamine, 1% (v/v) sodium pyruvate, 0.5% (v/v) nonessential
amino acids, 24 mM tissue culture grade b-mercaptoethanol,
supplemented with 10% (v/v) fetal bovine serum (FBS; BioSera,
East Sussex, UK) and 10% (v/v) L929-cell-conditioned medium
(LCM) as a source of Colony Stimulating Factor-1 (CSF-1) [29].
Cells in the bone marrow flush were plated onto non-treated
bacteriological petri dishes (BD Falcon, Oxford, UK) in macro-
phage medium. After three days of incubation at 37uC, 5% CO2,
the non-adherent population was re-plated with fresh macrophage
medium. The adherent population was discarded. After a further
five days culture the non-adherent population was discarded,
whilst remaining adherent BMDM were harvested for experimen-
tation.
BMDM from Mmp102/2 mice [15] and wild-type littermates
(protocols approved by the Institutional Animal Care and Use
Committee at the University of Washington) were isolated as
above.
RNA Purification, Reverse Transcription and Quantitative
Real Time – PCR
For analysis of gene expression BMDM (56105) were
transferred into medium containing 0.2% FBS and exposed to
100 ng/mL c-irradiated Lipopolysaccharide (LPS) purified from
E. coli (0111:B4) for the duration of the experiment stated. Total
RNA was purified from BMDM cell lysates using the RNeasy
Minikit (Qiagen, West Sussex, UK) according to the manufac-
turer’s instructions and including an additional DNase 1
(Invitrogen Ltd, Paisley, UK) step. Purified mRNA (250 ng–
1 mg) was reverse transcribed to complementary DNA (cDNA)
using Superscript II Reverse Transcriptase (Invitrogen Ltd)
according to the manufacturer’s instructions. Quantitative real-
time PCR (qRT-PCR) reactions were performed using the 7500
Fast RT-PCR System and TaqmanH primers and probes
(Applied Biosystems, CA, USA) for murine metalloproteinases
as described in [30] and [31] and QuantiTect probe PCR
Master Mix (Qiagen) according to the manufacturer’s instruc-
tions. Forward and reverse primer and probe sequences for
TNFa were designed using Primer Express software (Applied
Biosystems; forward 59 –AGACCCTCACACTCAGAT-
CATCTTC–39, reverse 59 –CCACTTGGTGGTTTGC-
TACGA–39, and probe 59-FAM-CAAAATTCGAGTGA-
CAAGCCTGTAGCCCA-TAMRA -39). Steady state mRNA
expression was normalized against 18 s ribosomal RNA
expression using the comparative cycle threshold method
(DDCT). Statistical analysis of change in gene expression
between two sets of data was performed using the two-tailed
Student’s T-test on sample groups no smaller than n= 3.
MMP10 Protein Immunostaining
BMDM (26104 cells per 13 mm glass coverslip) under indicated
conditions were treated with 5 mM Monensin Sodium Salt for 3 h
to block intracellular protein transport [32] and then fixed with a
4% (w/v) Paraformaldehyde solution. Cell membranes were
permeablised with 0.1% (v/v) Triton X-100 and non-specific
binding was blocked with 10% (v/v) normal donkey serum
(DAKO, Ely, UK) before incubation with Sheep anti-MMP10
polyclonal primary antibody [33]. BMDM were washed to remove
unbound primary antibody before incubation with Donkey anti-
Sheep Alexa-Fluor 488 conjugated polyclonal IgG secondary
antibody (Molecular Probes/Invitrogen, Paisley, UK). Before
mounting with Hydromount mounting medium (National Diag-
nostics, GA, USA), 49,6-diamidino-2-phenylindole (DAPI) nuclear
stain was applied.
Gene Silencing
BMDM (1.56104) were seeded onto 10 mg/mL bovine plasma
fibronectin (Calbiochem/Merck, Nottingham, UK) coated plastic
wells 24 h prior to transfection. 15 nM lyophilised siGENOME
SMARTpool siRNA targeting mouse MMP10 (siMMP10; 59-
GAAUUGAGCCACAAGUUGA-39, 59-GAGAUGUUCA-
CUUCGAUGA-39, 59-CCUCAGGGACCAACUUAUU-39.
MMP10 Modulates Macrophage Migration
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Dharmacon, CO, USA) and AllStars Negative Control (59-
GGGAAGUCCUAUUCUUUAA-39. Qiagen, West Sussex,
UK) were combined with HiPerfect Transfection Reagent
(Qiagen) and added to BMDM a further 24 h before time-lapse
microscopy began. Where stated, 3 ng/mL recombinant human
(r)MMP10 [34], was added to BMDM cultures for 6 h before
time-lapse microscopy.
2D Cell Migration Assay and Time-lapse Microscopy
BMDM were seeded onto plastic wells (24 well plates) coated
with rat tail collagen I (BD Biosciences, Oxford, UK), human
plasma fibrinogen (Calbiochem/Merck) or bovine plasma fibro-
nectin (all ECM components at 10 mg/mL). BMDM in 24 well
plates (alone or transfected with siRNA for MMP10 as indicated)
were transferred to a motorised stage within a controlled
environment chamber, also at 37uC, 5% CO2. Cells were imaged
every 10 minutes for 17 h with the AxioCam ICm 1 monochrome
CCD camera attached to the Axiovert 200M wide field inverted
light microscope using Axiovision 4.8.2 software (all Carl Zeiss
Ltd, Herts, UK). Cell migration speed was determined following
measurement of distance translocated by cells using ImageJ
software [35] with gel-ins ‘Manual Tracking’ (F. Cordelie`res,
Institute Curie, France) and ‘Chemotaxis and Migration Tool’
(Trapp and Horn, Ibidi GmbH, Germany).
3D Inverted Invasion Assay and Confocal Imaging
The 3D inverted invasion assay was performed as described
previously [36] with some modifications. Briefly, 100 mL of
Matrigel (BD Biosciences; stock mixed 1:1 with ice-cold PBS
and supplemented with bovine plasma fibronectin to a final
concentration of 50 mg/mL), was transferred to a TranswellTM
insert (8 mm pore; Corning, NY, USA) to polymerise at 37uC, 5%
CO2. After polymerisation, Transwell
TM inserts were inverted and
56104 wild-type or Mmp102/2 BMDM were applied directly to
the underside of the insert filter and allowed to adhere for 2 h,
before further inversion and gentle washing to remove any non-
adherent cells. Finally, TranswellTM inserts were placed into a
chamber containing macrophage medium whilst 100 ng/mL LPS
was applied to the upper TranswellTM chamber to establish a
chemotactic gradient through the Matrigel/fibronectin gel.
TranswellTM cultures were incubated for 72 h to allow invasion
into the gel. Cells were then stained with 4 mM Calcein-AM
(Molecular Probes/Invitrogen). Confocal images of cells adherent
to the filter were obtained, to confirm cell adhesion had remained
constant across conditions during the experiment. These cells were
then removed with a cotton swab to ensure only migrating cells
were analysed. Serial confocal optical sections (20 mm) of the
Matrigel/fibronectin gel were captured with a Leica TCS SP2
laser scanning confocal microscope and LCS software package
(Leica Microsystems Ltd, Bucks, UK). For each experimental
condition the inverted invasion assay was performed in duplicate
Transwells and confocal data was collected from 3 fields of view
per Transwell (6 fields of view in total). Experiments were repeated
with cells independently isolated from 2 mice per genotype.
Invasion data was quantified using ImageJ software (NIH) with
gel-in ‘Area Calculator’ (Sergio Caballero, University of Florida,
USA).
Unless otherwise stated all experiments were performed at least
3 times, with a representative experiment shown. Statistical
analysis was performed using Student’s t-test.
Results
LPS Differentially Regulates the Expression of
Metalloproteinases in Both BMDM and Raw264.7
Macrophages
Taking an unbiased approach to determine the effect of LPS on
steady state mRNA metalloproteinase and TIMP expression in
BMDM, qRT-PCR profiling of all MMPs, and TIMP1-4 was
performed on BMDM exposed to LPS for 24 h (Figure 1). In
addition expression of ADAMs 8, 15, 17, 33, ADAMTS1 and 4
was determined as they are known to be expressed in human
monocytic cells following differentiation [10] and/or have been
associated with inflammation [37,38]. Since the Raw264.7
macrophage cell line is often used as a model system for
macrophages, we also assessed the response of these cells to LPS
(Figure 1). Table 1 depicts those MMPs, ADAMs and TIMPs
whose steady state mRNA expression was significantly regulated
by LPS in these two macrophage populations (confirmed in 2
further experiments). In BMDM, expression of several MMPs was
up-regulated as previously reported, including MMP9 [39,40] and
MMP14 [41]. Although MMP12 was significantly down-regulated
by LPS, this proteinase was still highly expressed (data not shown).
Expression of MMPs was also differentially regulated by LPS in
Raw264.7 cells with several genes regulated in a similar manner to
those in BMDM (MMP10, 11, 14, and 25). Some differences were
observed, however. For example, whilst MMP2 was significantly
up-regulated in BMDM, expression was not detected under any
condition in Raw264.7 cells. Several MMPs were not expressed in
either BMDM or Raw264.7 in either untreated or LPS-treated
cells. Expression of ADAM8 and 15 was partially repressed in
BMDM by LPS. Amongst the TIMPs only TIMP2 expression was
partially but significantly repressed in both BMDM and Raw264.7
cells.
Steady-state mRNA Levels of MMP10 are Differentially
Regulated by LPS Over Time and in an NF-kB-dependent
Manner
Novel MMP regulation in BMDM by LPS included the
significant repression of MMP10 at 24 h (Table 1). Given that
LPS is typically regarded as an inducer of MMP expression, we
explored MMP10 expression at an earlier time point. Interestingly,
LPS significantly induced expression of MMP10 at 3 h (Figure 2A),
with expression returning to basal levels by 8 h (Figure S1).
MMP10 expression was repressed up to 7-fold below basal levels
by LPS at 24 h (Figure 2A) and in a dose-dependent manner
(Figure 2B). Importantly, the repression of MMP10 expression by
LPS was also observed at the protein level as revealed by
immunolocalisation in BMDM treated with the intracellular
protein transport inhibitor, monensin, thus preventing MMP
secretion (Figure 2C). We took this approach because levels of
MMP10 secreted by murine BMDM are low and do not permit
ready detection by Western blotting. TNFa expression was
markedly induced in BMDM at 3 h and remained highly
expressed at 24 h post-stimulation (Figure 2D) confirming that
LPS mediated a predictable pro-inflammatory response in these
cells. An extended time-course of MMP10 expression revealed that
by 48 h after LPS treatment steady state mRNA levels for MMP10
had returned to basal levels (Figure S1).
To address the potential mechanisms involved in MMP10
expression in macrophages, the effect of the IkB kinase (IKK)
inhibitor BMS-345541 was assessed. Inhibition of IKK repressed
LPS induction of MMP10 and TNFa at 4 h in Raw264.7 cells
(Figure 3A, upper and lower panels respectively) and also in
MMP10 Modulates Macrophage Migration
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BMDM at 3 h (Figure 3C). Interestingly, this inhibitor also largely
reversed the LPS-mediated repression of MMP10 at 24 h in
Raw264.7 cells (Figure 3B, upper panel) suggesting that LPS
regulates MMP10 expression via an NF-kB-dependent mecha-
nism. However, endogenous expression of MMP10 at 24 h was
not inhibited by the IKK inhibitor (Figure 3B, upper panel)
suggesting that other signalling pathways must be involved. TNFa
induction in Raw264.7 cells was also repressed at 24 h (Figure 3B,
lower panel). BMS-345541 proved toxic to BMDM at 24 h such
that no data could be generated. Taken together these data suggest
that the NF-kB pathway is involved in both the induction and
repression of MMP10 by LPS.
BMDM Migrate Across Several ECM Substrates Showing a
Preference for Fibronectin
As MMP10 has been suggested to affect migration of other
cell types [42], we hypothesised that its endogenous expression
may play a similar role in BMDM motility. We first determined
an optimal substrate for these cells in 2D time-lapse random
migration assays, selecting three substrates of relevance to
macrophage biology. A 2D substrate of fibronectin resulted in
the highest BMDM random migration speed (Figure 4A, left
panel), similar to that observed over fibrinogen. Macrophages
migrating over fibronectin showed significantly enhanced net
cell translocation (Figure 4B) compared to either collagen I or
fibrinogen (Figure 4A, upper panel). Corresponding plots of
BMDM migration reflect these observations (Figure 4C). Col-
lagen I was a poor substrate for macrophage adhesion, failing to
induce cell spreading (inset Figure 4C left panel) although
supporting migration of the still-rounded cells (Figure 4C left
panel).
Gene Silencing of Endogenous MMP10 Represses
Random Migration of BMDM
To explore the role of endogenously expressed MMP10 in
BMDM migration, we used a gene silencing approach, transfect-
ing BMDM with siRNA targeting MMP10 (siMMP10), which was
verified at both mRNA (Figure 5A) and protein levels (Figure 5B)
Figure 1. LPS regulates steady state expression of metallopro-
teinases and TIMPs in Raw264.7 macrophages and in BMDM.
Macrophages were cultured alone or in indicated concentrations of LPS
for 24 h prior to RNA extraction, reverse transcription and qRT-PCR
analysis. A heat map represents the mean expression in CT value for
triplicate samples. The cycle threshold (CT) value indicates the number
of PCR cycles required for the amplification of target cDNA to reach an
arbitrary threshold level. A low CT value indicates a greater level of
target cDNA present; therefore fewer cycles are needed to reach the
threshold.
doi:10.1371/journal.pone.0063555.g001
Table 1. The regulation of metalloproteinases and TIMPs in
response to LPS.
BMDM Raw264.7
MMP2 q* –
MMP3 no effect q*
MMP8 no effect q*
MMP9 q* no effect
MMP10 Q*** Q***
MMP11 Q* Q**
MMP12 Q* no effect
MMP13 no effect q***
MMP14 q*** q**
MMP15 Q** no effect
MMP21 – Q*
MMP25 q*** q***
MMP27 Q*** –
MMP28 no effect q***
TIMP2 Q*** Q*
ADAM8 Q* no effect
ADAM15 Q* no effect
*p#0.05.
**p#0.01.
***p#0.001.
‘–’ indicates no expression.
Primary BMDM and Raw264.7 macrophages were cultured with 100 ng/mL LPS
for 24 h prior to RNA extraction, reverse transcription and qRT-PCR analysis.
Arrows indicate trend change of gene expression compared to untreated
samples. Only expression changes of greater than 1 CT are included.
doi:10.1371/journal.pone.0063555.t001
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by immunofluorescence of monensin-treated cells. Transfection of
BMDM with siMMP10 resulted in an approximately 3-fold
reduction in cell migration speed and a significant reduction in net
cell translocation compared to scrambled siRNA transfection
(Figure 5C, upper and lower panels; corresponding cell tracks in
Figure 5D). Importantly, the reduction in migration speed driven
by siMMP10 could be rescued by the addition of exogenous
rMMP10 protein (Figure 5C, D). Interestingly, the further
addition of rMMP10 to scrambled siRNA-transfected cells did
not enhance BMDM speed any further, suggesting that the
endogenous level of MMP10 is sufficient to produce the maximum
migration effect under these conditions. These results demonstrate
that endogenous MMP10 expression plays a role in macrophage
migration over a fibronectin substrate.
BMDM from Mmp102/2mice have Substantially Impaired
Migration Over a Fibronectin Substrate
To further substantiate a role for MMP10 in BMDMmigration,
similar 2D migration assays were performed on a fibronectin
substrate with BMDM differentiated from the bone marrow of
MMP10 null (Mmp102/2) mice. Mmp102/2 BMDM showed a
significant 2-fold reduction in cell migration speed (0.31+/
20.03 mm/h compared to 0.7+/20.05 mm/h for wild-type cells)
as well as a significant reduction in net cell translocation compared
to wild-type littermate-derived BMDM (Figure 6A, upper and
lower panels). The migration deficit observed in Mmp102/2
BMDM was rescued by the addition of rMMP10 (0.96+/
20.08 mm/h) and examples of cell tracks of BMDM migration
are depicted in Figure 6B.
MMP10 is Necessary for Invasion of BMDM into a
Reconstituted 3D ECM Matrix
Since macrophages migrate over 2D surfaces, such as the
endothelium, but also through 3D matrices, such as the basement
membrane, the ability of BMDM to invade a thick layer of
Matrigel, supplemented with fibronectin, was explored. In these
experiments we used LPS as a chemoattractant, but since the end-
point of our experiments was at 72 h any effect of LPS on MMP10
expression will have subsided, since MMP10 expression returns to
basal levels by 48 h (Figure S1). A gradient of LPS induced wild-
type BMDM invasion whilst Mmp102/2 BMDM showed a 3-fold
reduced ability to invade (Figure 7A; representative montages of
confocal sections shown in Figure 7B). Importantly approximately
similar numbers of Mmp102/2 BMDM and their wild-type
counterparts were apparent on the underside of the filter as
assessed at the end-point of the experiment, prior to imaging
invasion (Figure S2). These results suggest that MMP10 plays a
key role in macrophage invasion into a 3D matrix.
Figure 2. Macrophage MMP10 expression is modulated in a time-dependent manner in response to LPS. (A) Increased steady-state
levels of MMP10 mRNA 3 h post-LPS treatment in BMDM and decreased levels of MMP10 mRNA 24 h post-LPS treatment as determined by qRT-PCR.
(B) Repression of MMP10 mRNA expression following 24 h LPS treatment is dose-dependent. (C) Immunofluorescence reveals decreased levels of
MMP10 protein (green) expressed by BMDM 24 h post-LPS treatment compared to untreated cells (all cells treated with monensin). DAPI nuclear
stain is shown in blue [scale bar = 25 mm]. (D) BMDM expression of TNFamRNA is increased 3 h post-LPS treatment and remains enhanced 24 h post-
LPS treatment. All mRNA expression is normalised to 18S endogenous control. **p#0.01, ***p#0.001 (Student’s T test). Each bar represents mean 6
S.E.M. of at least 3 samples. Experiments were performed 3 times and a representative experiment is shown.
doi:10.1371/journal.pone.0063555.g002
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Discussion
Macrophage migration is implicated in both normal and
pathological conditions: it is essential for wound healing and
immune responses but is an unwanted response in inflammatory
conditions such as atherosclerosis and chronic wounds. In this
study a comprehensive survey of metalloproteinase expression has
revealed novel regulation of MMP10 in response to LPS. Further
study uncovered a functional role for this metalloproteinase in the
migration of macrophages on 2D components of ECM as well as
in 3D invasion.
Regulation of Metalloproteinase Expression in BMDM
and Raw264.7 Macrophages by LPS
Comparison of BMDM and the Raw264.7 macrophage cell line
response to LPS stimulation for 24h revealed that although some
genes were differentially modulated in the two cell populations,
others were significantly regulated in a similar manner. For
example; up-regulation of expression of MMP14 and 25 was
observed in both populations whereas that of MMP2 and 9 was
induced only in BMDM. Regulation of MMP14 was in agreement
with previous observations in human monocytes [8,43]. MMP14
has been implicated in the migration of human monocytes in
response to chemoattractant stimuli on a number of substrates,
including fibronectin [23]. MMP25 (MT3-MMP) has been shown
previously to be up-regulated in macrophages of atherosclerotic
plaques, indicating a potential inflammatory association [11] and
was here found to be significantly up-regulated in both Raw 264.7
macrophages and BMDM in response to LPS. Expression of
several metalloproteinases was partially down-regulated in BMDM
following exposure to LPS for 24 h. These include MMP12,
implicated in macrophage migration [4], and MMP15 (MT2-
MMP), whose function in macrophages remains to be established.
The expression of MMP10 in response to LPS was of great
interest since this proteinase seems to be increasingly associated
with inflammation in a variety of physiological and pathological
conditions. Induction of MMP10 by LPS in primary human
monocytes has been shown previously at 4 h [44] and we have
confirmed these results in murine BMDM and Raw264.7 cells.
TNFa was elevated more than 10-fold at 3 h after LPS stimulation
and others have demonstrated substantial secretion of this cytokine
from macrophages within 4 h [45]. TNFa may be responsible for
Figure 3. The time-dependant effects of LPS on macrophage MMP10 expression are sensitive to NF-kB inhibition. (A) Induction of
MMP10 (above) and TNFa mRNA (below) in LPS-treated Raw264.7 macrophages was abrogated by IKK inhibitor BMS-345541 at 4 h as determined by
qRT-PCR (B) The repression of MMP10 mRNA (above) 24 h post-LPS treatment was also reversed by BMS-345541 (below) whilst TNFa induction was
still repressed (right). (C) Abrogation of MMP10 (left) and TNFa (right) expression was also observed in the presence of BMS-345541 in BMDM 3 h
post-LPS exposure. *p#0.05, relative to untreated samples, #p#0.05, relative to LPS alone (Student’s T test). Each bar represents mean 6 S.E.M. of at
least 3 samples. Experiments were performed 3 times and a representative experiment is shown.
doi:10.1371/journal.pone.0063555.g003
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MMP10 induction in this early time-frame, since TNFa can
induce some MMP genes within one hour of stimulation, at least
in other cell types [46]. In our study, treatment with an IKK
inhibitor suppressed both endogenous and induced MMP10 and
TNFa at 4 h in macrophages, supportive of a role for the NF-kB
pathway in MMP10 expression/up-regulation. Recently, Huang
and colleagues [47] have demonstrated that LPS/IFNc treatment
leads to induction of MMP10 expression in human monocytes
which is mediated by several pathways, including NF-kB. These
authors also co-localised MMP10 with NF-kB in macrophage-rich
areas of human atherosclerotic plaques, lending support to a role
for NF-kB in MMP10 regulation in vivo. Previous studies have
shown that TNFa induces MMP10 expression in intestinal
epithelial cells [48] and MMP10 expression in chondrocytes is
also repressed by IKKb inhibition [49]. MMP10 is induced in the
tracheal epithelium of mice infected with the gram-negative
bacterium P. aeruginosa, and mediates a range of transcriptional
responses. Furthermore, analysis of known key gene interaction
networks involved in host response to infection with P. aeruginosa
suggested a role for NF-kB in the regulation this MMP [15].
Overall, our data are in keeping with the idea that the up-
regulation of MMP10 by LPS at 4 h may be mediated through an
NF-kB-dependent mechanism, and it has previously been shown
that TNFa-induced MMP10 expression is Rel A/p65 dependent
Figure 4. Fibronectin is a good substrate for random migration of primary macrophages. BMDM were cultured on thin coatings of
collagen I, fibrinogen or fibronectin for 24 h. (A) Time-lapse microscopy analysis reveals no significant variation in speed of macrophage migration
(above), however net cell translocation (below), is significantly enhanced on fibronectin when compared to other conditions. *p#0.05, ***p#0.001
relative to fibronectin (Student’s T test). Each bar represents mean6 S.E.M. of at least 10 cell tracks. (B) Schematic explanation of net cell translocation
by cells. (C) Migration plots illustrate the enhanced motility of macrophages on fibronectin. Insets: stills from time-lapse recordings. Note cells on
collagen I remain rounded. Experiments were performed 3 times and a representative experiment is shown.
doi:10.1371/journal.pone.0063555.g004
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Figure 5. Repression of random macrophage migration on fibronectin by gene silencing of MMP10 and rescue by the exogenous
application of soluble rMMP10. (A) qRT-PCR analysis reveals successful repression of MMP10 mRNA expression in BMDM transfected with
siMMP10 compared to scrambled control siRNA. ***p#0.001. Each bar represents mean 6 S.E.M. of at least 3 samples. (B) MMP10 protein
immunolocalisation in BMDM 24 h post-transfection with siMMP10 shows repression of protein levels compared to scrambled control siRNA and
secondary (2u) antibody only control, (all cells treated with monenesin), [scale bar = 25 mm]. (C) Time-lapse microscopy analysis reveals a significant
reduction in the speed of BMDM migration (above) on fibronectin following siMMP10 transfection, which was rescued by exogenous rMMP10.
Analysis of net cell translocation (below) confirms the siMMP10 driven reduction in migration. (D) Corresponding migration plots reflect the effect of
siMMP10 and rMMP10 on macrophage motility. ***p#0.001 (Student’s T test). Each bar represents mean 6 S.E.M. of at least 10 cell tracks.
Experiments were performed 3 times and a representative experiment is shown.
doi:10.1371/journal.pone.0063555.g005
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[50]. However, further investigation is needed to substantiate the
involvement of this pathway in our system.
Potential Mechanisms Underpinning Repression of
MMP10 Expression
At 24 h following LPS treatment steady-state mRNA levels for
MMP10 were substantially repressed 7-fold below basal levels with
very little expression observed at the protein level at this time-
point. It should be noted that others have observed up-regulation
of MMP10 expression by LPS treatment in human monocytes at
18 h [8], which may be a reflection of the shorter time of exposure
and/or species. It is possible that in human monocytes MMP10
expression maintains a prolonged elevation. It is of interest to note
that, whilst at 24 h expression of MMP10 is suppressed, TNFa
expression remains high, indicating that this cytokine is likely not
implicated in regulating MMP10 expression at this later time-
point. The time-dependent repression of MMP10 expression
following LPS treatment we observed in both BMDM and
Raw264.7 macrophages may reflect the effect of several signalling
pathways. Interestingly pharmacological inhibition of IKK largely
reversed LPS-driven differential MMP10 expression, indicating
NF-kB pathway involvement. The potential role of NF-kB in
Figure 6. Mmp102/2 macrophages display reduced migration that can be rescued with the exogenous application of soluble
rMMP10. BMDM from the Mmp102/2 mouse and their back-crossed wild-type (WT) litter-mates were cultured on fibronectin for 24 h before the
addition of rMMP10 as indicated. (A) Time-lapse microscopy analysis of Mmp102/2 BMDM (squares) reveals significantly reduced migration speed
(above) and net cell translocation distance (below) compared to wild-type BMDM (circles). Exogenous application of rMMP10 to the culture medium
of Mmp102/2 BMDM (triangles) enhances migration speed (above) and net cell translocation (below) to levels comparable to wild-type BMDM
(circles). (B) Examples of migration plots reflect the effect on BMDM motility. ***p#0.00.1 (Student’s T test). Data depicts mean 6 S.E.M. of at least 60
cell tracks in combined data from cells isolated in two independent experiments (2 mice per genotype).
doi:10.1371/journal.pone.0063555.g006
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MMP10 repression is further supported by the elegant study of
Treiber et al. [51], who have demonstrated that LPS treatment of
BMDM from mice with functionally inactive RelA/p65 (resulting
in abrogation of NFKB signalling) results in up-regulation of
MMP10 expression, in keeping with our observations at 24 h post-
LPS treatment.
Epigenetic mechanisms of MMP10 regulation have also been
reported with histone deacetylase (HDAC)7 shown to repress
MMP10 expression in endothelial cells through sequestration of
the transcription factor MEF2 [52]. In addition, under TNFa
stimulation HDAC7 dissociates from MEF2 making MEF2
available, allowing subsequent transcription of MMP10 [53].
LPS up-regulates expression of MEF2 in monocytes [54] as well as
HDAC7 in BMDM [55], which could result in overall MMP10
suppression depending on relative levels of these proteins. In our
hands we did not observe modulation of HDAC7 expression at the
mRNA level although we did observe repression of HDAC5 by
LPS (data not shown) and it is noteworthy that HDAC5 can also
bind to and regulate expression of MEF2 (reviewed in [56]).
However given that HDAC7 and MEF2 [54] are also regulated
through phosphorylation events, mRNA levels of HDAC7 may
not be as important as protein localisation, following LPS
treatment. Zinc finger protein 267 (ZNF267) has also been
reported to act as a transcriptional repressor of MMP10 expression
in hepatic stellate cells, in an HDAC-independent manner [57].
However, these authors commented that LPS does not transacti-
vate ZF267, thus making it less likely to be involved in our system.
MicroRNAs are implicated in repression of many genes and a
candidate in our system may be miR-155 since this microRNA has
been shown to be involved in LPS regulation of several pathways
in dendritic cells [58]. Future studies will determine whether these
pathways are involved in the LPS-mediated repression of MMP10.
MMP10 Regulation of Cell Migration
In both 2D time-lapse migration assays and in 3D invasion we
have shown that MMP10 is a key player in macrophage migration.
Whilst MMP10 has not previously been studied in macrophage
migration, its exogenous expression has been associated with
migrating keratinocytes in wound healing with MMP10 inducing
keratinocyte migration in vitro [42]. MMP10 is regulated in a
spatiotemporal manner during wound healing, with strong
expression at both day 1 and day 5 post-wounding [59] and has
been observed in macrophage-rich areas of the dermis in human
skin ulcers [60]. We have similarly localised MMP10 in
macrophage-rich areas of granulation tissue of mouse skin wounds
(Murray, Bevan and Gavrilovic unpublished observations). Of
interest, circulating MMP10 levels have been correlated with
markers of inflammation and increased atherosclerotic plaques in
patients with elevated cardiovascular disease risk [61]. In addition,
circulating levels of MMP10 are significantly higher in patients
with sepsis [62], suggesting an important role for this proteinase
during infection.
Current concepts of leukocyte cell migration and cell-matrix
interactions have been established in 2D models [63,64,65].
Leukocytes adhere to the undulating, 2D, layer of activated
endothelium lining the blood vessel lumen; rolling then crawling
over it, before subsequent diapedesis and invasion through the
basement membrane and underlying stroma (reviewed in [66,67]).
LPS has been shown to act as a chemo-attractant for macrophages
[68] and we confirm here the ability of LPS to induce macrophage
invasion when applied across an ECM gel. The ability of LPS to
induce invasion may seem contradictory given our observations
regarding MMP10 suppression, however, the steady-state levels of
MMP10 have returned to basal levels by 48 h post-LPS exposure
and given our invasion assay end point is at 72 h any suppressive
role of LPS will have long since subsided.
Our experiments thus highlight a central role for metallopro-
teinases, with both 2D migration and 3D invasion of BMDM
found to be MMP10-dependent. Mechanistically, migration and
invasion have been shown to have several different characteristics
(reviewed in [69]) and invasion of some cell lines through Matrigel
has been shown by others to be independent of proteolytic activity
[70]. However, it is possible that MMP10 cleaves the fibronectin
substrate present in our model, and/or cell surface molecules such
as syndecans, or endogenous chemokines, as reported for other
MMPs (reviewed in [3]). Importantly, others have shown that
Figure 7. Invasion through a 3D Matrigel/fibronectin gel is
impaired in Mmp102/2 macrophages. An inverted invasion assay
was performed to compare 3D invasion of BMDM from the Mmp102/2
mouse and their back-crossed wild-type litter-mates. BMDM were
allowed to invade into a Matrigel/fibronectin gel for 72 h along a
gradient of LPS. (A) Relative invasion was quantified by measuring the
fluorescence intensity of Calcein-AM staining in BMDM penetrating
$20 mm into the gel as a percentage of the total fluorescence intensity
of all cells within the gel, and is expressed relative to untreated wild-
type BMDM invasion. **p#0.01, ***p#0.001. Each bar represents
mean6 S.E.M. for combined data collected from a total of 12 fields of
view (3 per gel) for cells isolated independently from 2 mice per
genotype. (B) Invading wild-type and Mmp102/2 BMDM were stained
with Calcein-AM and visualised by confocal microscopy. Serial optical
sections were captured at 20 mm intervals and typical examples, with
and without LPS gradient, are presented in sequence, left to right.
doi:10.1371/journal.pone.0063555.g007
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cysteine proteinases, including cathepsin B, can mediate macro-
phage invasion [71,72] suggesting that proteinase involvement
may be context- and stimulus-dependent.
In conclusion our studies demonstrate a key role for MMP10 in
both 2D and 3D migratory contexts and future studies will
uncover the precise roles played by this metalloproteinase, which is
of emerging importance in macrophage biology.
Supporting Information
Figure S1 An extended time course of macrophage
MMP10 expression following treatment with LPS. Steady
state mRNA levels for MMP10 are elevated at 4 h, return to basal
levels by 8 h and are repressed at 24 h. By 48 h MMP10
expression levels return to untreated levels and a similar level of
expression is observed at 72 h.
(TIF)
Figure S2 Typical examples to demonstrate approxi-
mately equal numbers of wild-type and Mmp102/2
BMDM adhering to the lower surface of the TranswellTM
filters for the inverted invasion assay. BMDM were stained
with Calcein-AM and visualised by confocal microscopy.
(TIF)
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